Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8K Buy
1,093
+129
+13% +$2.15K ﹤0.01% 517
2025
Q4
$17.4K Sell
964
-52
-5% -$895 ﹤0.01% 523
2025
Q3
$16.4K Buy
1,016
+199
+24% +$2.91K ﹤0.01% 513
2025
Q2
$8.9K Hold
817
﹤0.01% 581
2025
Q1
$10.2K Buy
817
+146
+22% +$2.4K ﹤0.01% 561
2024
Q4
$13.3K Buy
+671
New +$7.43K ﹤0.01% 512

Other funds holding MESO

GF Fund Management's MESO Position: Q1 2026 in Review

GF Fund Management increased its Mesoblast (MESO) stake by 13% in Q1 2026, buying an estimated $2.15K and bringing the position to 1,093 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

GF Fund Management first reported a position in MESO in Q4 2024 and has held it in 6 quarters since. The position peaked at $17.4K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • GF Fund Management held 1,093 shares of Mesoblast worth $16.8K as of Q1 2026.
  • GF Fund Management bought 129 Mesoblast shares in Q1 2026, an estimated $2.15K.
  • Mesoblast made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #517 holding.
  • GF Fund Management first reported a position in Mesoblast in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Mesoblast position peaked at $17.4K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.